SK4332003A3 - Crystal form of 1-[6-chloro-5-(trifluoromethyl)-2- pyridinyl]piperazine hydrochloride, process for the preparation thereof, pharmaceutical composition comprising same, and its use - Google Patents
Crystal form of 1-[6-chloro-5-(trifluoromethyl)-2- pyridinyl]piperazine hydrochloride, process for the preparation thereof, pharmaceutical composition comprising same, and its use Download PDFInfo
- Publication number
- SK4332003A3 SK4332003A3 SK433-2003A SK4332003A SK4332003A3 SK 4332003 A3 SK4332003 A3 SK 4332003A3 SK 4332003 A SK4332003 A SK 4332003A SK 4332003 A3 SK4332003 A3 SK 4332003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- trifluoromethyl
- chloro
- org
- crystalline form
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3403—Needle locating or guiding means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/489—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3403—Needle locating or guiding means
- A61B2017/3405—Needle locating or guiding means using mechanical guide means
- A61B2017/3409—Needle locating or guiding means using mechanical guide means including needle or instrument drives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/34—Trocars; Puncturing needles
- A61B17/3403—Needle locating or guiding means
- A61B2017/3413—Needle locating or guiding means guided by ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/44—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00203528 | 2000-10-13 | ||
| PCT/EP2001/011714 WO2002030902A1 (en) | 2000-10-13 | 2001-10-09 | Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK4332003A3 true SK4332003A3 (en) | 2003-10-07 |
Family
ID=8172124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK433-2003A SK4332003A3 (en) | 2000-10-13 | 2001-10-09 | Crystal form of 1-[6-chloro-5-(trifluoromethyl)-2- pyridinyl]piperazine hydrochloride, process for the preparation thereof, pharmaceutical composition comprising same, and its use |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20040038985A1 (es) |
| EP (1) | EP1326837A1 (es) |
| JP (1) | JP2004512282A (es) |
| KR (1) | KR20030060906A (es) |
| CN (1) | CN1469863A (es) |
| AU (1) | AU2002220614A1 (es) |
| BR (1) | BR0114609A (es) |
| CA (1) | CA2425540A1 (es) |
| EC (1) | ECSP034549A (es) |
| HR (1) | HRP20030246A2 (es) |
| HU (1) | HUP0302842A2 (es) |
| IL (1) | IL154982A0 (es) |
| IS (1) | IS6758A (es) |
| MX (1) | MXPA03003233A (es) |
| NO (1) | NO20031698D0 (es) |
| PL (1) | PL366055A1 (es) |
| RU (1) | RU2003113536A (es) |
| SK (1) | SK4332003A3 (es) |
| WO (1) | WO2002030902A1 (es) |
| ZA (1) | ZA200302520B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008004944A1 (en) * | 2006-07-04 | 2008-01-10 | Astrazeneca Ab | Novel crystalline form ii |
| WO2008004945A1 (en) * | 2006-07-04 | 2008-01-10 | Astrazeneca Ab | Novel crystalline forms i and ii |
| CZ303950B6 (cs) * | 2011-12-12 | 2013-07-10 | Masarykova Univerzita | Zpusob prípravy 1-(pyridin-4-yl)piperazinu a jeho 1,1-dialkyl-1-ium derivátu |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68912282T2 (de) * | 1988-11-24 | 1994-04-28 | Akzo Nv | 1-[Mono- oder bis(trifluormethyl)-2-pyridinyl]piperazine enthaltende pharmazeutische Zusammensetzungen. |
| WO1998033504A1 (en) * | 1997-02-03 | 1998-08-06 | Akzo Nobel N.V. | Treatment of urinary incontinence |
-
2001
- 2001-10-09 BR BR0114609-2A patent/BR0114609A/pt not_active Application Discontinuation
- 2001-10-09 PL PL01366055A patent/PL366055A1/xx not_active Application Discontinuation
- 2001-10-09 CA CA002425540A patent/CA2425540A1/en not_active Abandoned
- 2001-10-09 SK SK433-2003A patent/SK4332003A3/sk unknown
- 2001-10-09 JP JP2002534288A patent/JP2004512282A/ja not_active Withdrawn
- 2001-10-09 IL IL15498201A patent/IL154982A0/xx unknown
- 2001-10-09 US US10/398,991 patent/US20040038985A1/en not_active Abandoned
- 2001-10-09 HU HU0302842A patent/HUP0302842A2/hu unknown
- 2001-10-09 AU AU2002220614A patent/AU2002220614A1/en not_active Abandoned
- 2001-10-09 MX MXPA03003233A patent/MXPA03003233A/es unknown
- 2001-10-09 WO PCT/EP2001/011714 patent/WO2002030902A1/en not_active Ceased
- 2001-10-09 CN CNA018172571A patent/CN1469863A/zh active Pending
- 2001-10-09 HR HR20030246A patent/HRP20030246A2/hr not_active Application Discontinuation
- 2001-10-09 EP EP01986679A patent/EP1326837A1/en not_active Withdrawn
- 2001-10-09 RU RU2003113536/04A patent/RU2003113536A/ru not_active Application Discontinuation
- 2001-10-09 KR KR10-2003-7005122A patent/KR20030060906A/ko not_active Withdrawn
-
2003
- 2003-03-27 IS IS6758A patent/IS6758A/is unknown
- 2003-03-31 ZA ZA200302520A patent/ZA200302520B/en unknown
- 2003-04-08 EC EC2003004549A patent/ECSP034549A/es unknown
- 2003-04-11 NO NO20031698A patent/NO20031698D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2425540A1 (en) | 2002-04-18 |
| IS6758A (is) | 2003-03-27 |
| HUP0302842A2 (hu) | 2003-12-29 |
| RU2003113536A (ru) | 2004-11-10 |
| KR20030060906A (ko) | 2003-07-16 |
| ZA200302520B (en) | 2004-06-30 |
| BR0114609A (pt) | 2003-12-23 |
| CN1469863A (zh) | 2004-01-21 |
| WO2002030902A8 (en) | 2004-02-26 |
| HRP20030246A2 (en) | 2003-06-30 |
| EP1326837A1 (en) | 2003-07-16 |
| MXPA03003233A (es) | 2003-09-10 |
| US20040038985A1 (en) | 2004-02-26 |
| WO2002030902A1 (en) | 2002-04-18 |
| ECSP034549A (es) | 2003-05-26 |
| IL154982A0 (en) | 2003-10-31 |
| JP2004512282A (ja) | 2004-04-22 |
| PL366055A1 (en) | 2005-01-24 |
| AU2002220614A1 (en) | 2002-04-22 |
| NO20031698D0 (no) | 2003-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2970123B1 (en) | Salt of omecamtiv mecarbil and process for preparing salt | |
| EP2411394B1 (en) | Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one | |
| DE60125429T2 (de) | Zolpidem hemitartrat solvat | |
| JP5086069B2 (ja) | 重硫酸アタザナビルおよび新規形態の製造方法 | |
| HUE025209T2 (en) | Pyridine quinoline substituted pyrrolo [1,2-b] pyrazole monohydrate as TGF-beta inhibitor | |
| SK14742000A3 (sk) | Pyridazinónová hydrochloridová zlúčenina a spôsob jej prípravy | |
| DE60319980T2 (de) | Xanthin-phosphodiesterase-v-hemmer polymorphe | |
| JP2003527319A (ja) | トルセミド多形体 | |
| EP3327012B1 (en) | Crystalline forms of bilastine and preparation methods thereof | |
| SK4332003A3 (en) | Crystal form of 1-[6-chloro-5-(trifluoromethyl)-2- pyridinyl]piperazine hydrochloride, process for the preparation thereof, pharmaceutical composition comprising same, and its use | |
| JP2024163194A (ja) | フロピリミジン化合物の酸付加塩の結晶形 | |
| EP2085397A1 (en) | Crystalline form of abacavir | |
| SK283188B6 (sk) | Spôsob prípravy kryštalickej formy 3/2 hydrátu 7-[(7-(S)- amino-5-azaspiro[2.4]-heptan-5-yl]-8-chlór-6-flór-1-[(1R,2S)-2- flórcyklopropyl]-4-oxo-1,4-dihydrochinolín-3-karboxylovej kyseliny | |
| AU2004232495B2 (en) | 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo [2, 3d]pyrimidine hydrogen mesylate and its polymorphic forms | |
| DE69324794T2 (de) | Phenyl imidazolinon-derivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht3-rezeptor-antagonisten | |
| EP4190320A1 (en) | Crystalline form of phentermine hydrochloride and process for obtaining same | |
| KR20080106232A (ko) | 베시피르딘 클로하이드레이트의 결정형, 그 제조 방법 및 용도 | |
| WO2025130951A1 (zh) | Ad-35多晶型物及其制备方法和用途 | |
| US20050215600A1 (en) | Polymorphs of torsemide hydrochloride and process for production thereof | |
| SI21233A (sl) | Kristalni hidratni obliki amlodipin benzensulfonata visoke čistote, postopki za njuno pripravo in uporaba | |
| EP2154137A1 (en) | Crystalline form of moxifloxacin base | |
| JPWO2002020516A1 (ja) | 1,3,4−オキサジアゾール誘導体の新規結晶、その製造方法およびそれを有効成分として含有する薬剤 | |
| HK1218544B (en) | Salt of omecamtiv mecarbil and process for preparing salt |